Atossa Genetics (NASDAQ:ATOS) reported quarterly losses of $(0.06) per share. This is a 50 percent decrease over losses of $(0.04) per share from the same period last year.
Why Is Cancer Firm Apollomics Stock Trading Higher Today?
Apollomics Inc's (NASDAQ: APLM) partner in China, Avistone Biotechnology Co.